Pharmacokinetics of gene recombined angiogenesis inhibitor Kringle 5 in vivo using (131)I specific markers and SPECT/CT()

The previous pharmacokinetic methods can be only limited to drug analysis in vitro, which provide less information on the distribution and metabolismof drugs, and limit the interpretation and assessment of pharmacokinetics, the determination of metabolic principles, and evaluation of treatment effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Ge, Yang, Danrong, Yu, Yan, Xue, Jianjun, Jia, Yifan, Sun, Xuanzi, Wang, Boyu, Zhao, Zewei, Wang, Maode
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Xi'an Jiaotong University 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762626/
https://www.ncbi.nlm.nih.gov/pubmed/29403998
http://dx.doi.org/10.1016/j.jpha.2016.09.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5762626/
https://www.ncbi.nlm.nih.gov/pubmed/29403998
http://dx.doi.org/10.1016/j.jpha.2016.09.001

Ejemplares similares